Literature DB >> 31580948

Uncoupled human flavin-containing monooxygenase 3 releases superoxide radical in addition to hydrogen peroxide.

Gianluca Catucci1, Chongliang Gao1, Giulia Rampolla1, Gianfranco Gilardi1, Sheila J Sadeghi2.   

Abstract

Human flavin-containing monooxygenase 3 (hFMO3) is a drug-metabolizing enzyme capable of performing N- or S-oxidation using the C4a-hydroperoxy intermediate. In this work, we employ both wild type hFMO3 as well as an active site polymorphic variant (N61S) to unravel the uncoupling reactions in the catalytic cycle of this enzyme. We demonstrate that in addition to H2O2 this enzyme also produces superoxide anion radicals as its uncoupling products. The level of uncoupling was found to vary between 50 and 70% (WT) and 90-98% (N61S) for incubations with NADPH and benzydamine over a period of 5 or 20 min, respectively. For the first time, we were able to follow the production of the superoxide radical in hFMO3, which was found to account for 13-18% of the total uncoupling of this human enzyme. Moreover, measurements in the presence or absence of the substrate show that the substrate lowers the level of uncoupling only related to the H2O2 and not the superoxide radical. This is consistent with the entry point of the substrate in this enzyme's catalytic cycle. These findings highlight the importance of the involvement of hFMO3 in the production of radicals in the endoplasmic reticulum, as well as the relevance of single-nucleotide polymorphism leading to deleterious effects of oxidative stress.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Flavin-containing monooxygenase; Hydrogen peroxide; N61S; Polymorphic variant; Superoxide radical; Uncoupling

Year:  2019        PMID: 31580948     DOI: 10.1016/j.freeradbiomed.2019.09.038

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  1 in total

1.  Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas.

Authors:  Fei Ding; Jinping Li; Yong Zhang; Chengang Wang; Yonghua Yu
Journal:  Oxid Med Cell Longev       Date:  2022-07-22       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.